Inhibrx Biosciences GAAP EPS of -$1.85, revenue of $1.3M

* Inhibrx Biosciences press release [https://seekingalpha.com/pr/20200152-inhibrx-reports-second-quarter-2025-financial-results] (NASDAQ:INBX [https://seekingalpha.com/symbol/INBX]): Q2 GAAP EPS of -$1.85.
* Revenue of $1.3M.
*  

MORE ON INHIBRX BIOSCIENCES

* Inhibrx Biosciences: Seeing Soon If The Momentum Is Just Hype [https://seekingalpha.com/article/4802144-inhibrx-biosciences-stock-promising-data-but-challenging-area]
* Seeking Alpha’s Quant Rating on Inhibrx Biosciences [https://seekingalpha.com/symbol/INBX/ratings/quant-ratings]
* Historical earnings data for Inhibrx Biosciences [https://seekingalpha.com/symbol/INBX/earnings]
* Financial information for Inhibrx Biosciences [https://seekingalpha.com/symbol/INBX/income-statement]